Catalyst Wire Dossier Catalyst Wire Dossier

S6G5T-1

· Sol-Gel Technologies, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S6G5T-1, covering 2019-09-19 to 2019-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris [Phase 2]

See pricing